FHI vs. CNS: Which Stock Is the Better Value Option?

An analysis comparing Federated Hermes (FHI) and Cohen & Steers Inc (CNS) for value investors identifies FHI as the superior option. FHI holds a Zacks Rank of #1 (Strong Buy) versus CNS's #3 (Hold), indicating more favorable earnings estimate revision activity. Additionally, FHI presents more attractive valuation metrics, including a significantly lower forward P/E (12.12 vs. 25.21), PEG ratio (0.74 vs. 2.47), and P/B ratio (3.76 vs. 7.22), resulting in a 'B' Value grade compared to CNS's 'F'.

Analysis

A comparative analysis of Federated Hermes (FHI) and Cohen & Steers (CNS) identifies FHI as the superior option for value-oriented investors within the investment management sector. This conclusion is supported by the Zacks Rank system, where FHI holds a #1 (Strong Buy) rating, indicating positive earnings estimate revisions and an improving analyst outlook, while CNS is rated #3 (Hold). FHI exhibits significantly more attractive valuation metrics across the board. Its forward P/E ratio stands at 12.12, less than half of CNS's 25.21. Furthermore, FHI's PEG ratio of 0.74 suggests its price is undervalued relative to its earnings growth expectations, contrasting sharply with CNS's PEG of 2.47. The divergence is also evident in the price-to-book (P/B) ratio, with FHI at 3.76 compared to CNS's 7.22. These quantitative factors culminate in a Value grade of 'B' for FHI, whereas CNS receives an 'F', reinforcing FHI's stronger position based on this value-centric framework.

Key Decisions for Investors

• Given its 'Strong Buy' rating and substantially more favorable valuation metrics including a P/E of 12.12 and PEG of 0.74, value-focused investors should consider Federated Hermes (FHI) as a compelling investment opportunity.
• Investors holding or evaluating Cohen & Steers (CNS) should exercise caution due to its high valuation multiples, particularly a P/E of 25.21 and a PEG of 2.47, and its neutral 'Hold' rating, which suggest the stock may be overvalued compared to its peer.
• The primary drivers of this analysis are earnings estimate revisions and relative valuation; therefore, investors should monitor for any changes in analyst sentiment or fundamental metrics for either FHI or CNS that could alter this comparative thesis.